MGTX
Price
$6.54
Change
+$0.11 (+1.71%)
Updated
Jan 31, 11:23 AM (EDT)
Capitalization
485.72M
40 days until earnings call
PLRX
Price
$10.97
Change
+$0.32 (+3.00%)
Updated
Jan 31, 11:39 AM (EDT)
Capitalization
653.57M
32 days until earnings call
Ad is loading...

MGTX vs PLRX

Header iconMGTX vs PLRX Comparison
Open Charts MGTX vs PLRXBanner chart's image
MeiraGTx Holdings
Price$6.54
Change+$0.11 (+1.71%)
Volume$255
Capitalization485.72M
Pliant Therapeutics
Price$10.97
Change+$0.32 (+3.00%)
Volume$1.4K
Capitalization653.57M
MGTX vs PLRX Comparison Chart
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. PLRX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a StrongBuy and PLRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (MGTX: $6.43 vs. PLRX: $10.66)
Brand notoriety: MGTX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 76% vs. PLRX: 92%
Market capitalization -- MGTX: $485.72M vs. PLRX: $653.57M
MGTX [@Biotechnology] is valued at $485.72M. PLRX’s [@Biotechnology] market capitalization is $653.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 6 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • MGTX’s TA Score: 6 bullish, 0 bearish.
  • PLRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than PLRX.

Price Growth

MGTX (@Biotechnology) experienced а +5.93% price change this week, while PLRX (@Biotechnology) price change was -4.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.84%. For the same industry, the average monthly price growth was +1.79%, and the average quarterly price growth was +5.50%.

Reported Earning Dates

MGTX is expected to report earnings on May 08, 2025.

PLRX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($654M) has a higher market cap than MGTX($486M). MGTX YTD gains are higher at: 5.583 vs. PLRX (-19.058). MGTX has higher annual earnings (EBITDA): -61.2M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. MGTX (123M). PLRX has less debt than MGTX: PLRX (60.2M) vs MGTX (86.7M). MGTX has higher revenues than PLRX: MGTX (13.9M) vs PLRX (0).
MGTXPLRXMGTX / PLRX
Capitalization486M654M74%
EBITDA-61.2M-197.04M31%
Gain YTD5.583-19.058-29%
P/E RatioN/AN/A-
Revenue13.9M0-
Total Cash123M405M30%
Total Debt86.7M60.2M144%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGTXPLRX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 29 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGYX19.960.19
+0.96%
NYLI PineStone Global Equity Class C
DWOCX16.060.03
+0.19%
BNY Mellon Research Growth C
HDVSX12.32N/A
N/A
Hartford International Equity R4
IVPOX20.68N/A
N/A
Voya SmallCap Opportunities Port S
FEDMX38.29N/A
N/A
Fidelity Advisor Emerging Markets A

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with BEAM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+3.46%
BEAM - MGTX
52%
Loosely correlated
+5.29%
NTLA - MGTX
51%
Loosely correlated
+3.85%
AURA - MGTX
50%
Loosely correlated
+0.13%
CRSP - MGTX
49%
Loosely correlated
+2.01%
PLRX - MGTX
47%
Loosely correlated
-0.74%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.74%
RCKT - PLRX
51%
Loosely correlated
+2.69%
CRSP - PLRX
50%
Loosely correlated
+2.01%
PRME - PLRX
50%
Loosely correlated
+2.91%
NTLA - PLRX
49%
Loosely correlated
+3.85%
IDYA - PLRX
48%
Loosely correlated
-0.25%
More